SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tema ETF Trust - Tema Space Innovators ETF

Investors are aggressively accumulating this ETF as a primary vehicle for pre-IPO exposure to SpaceX, driving significant momentum ahead of the highly anticipated public listing. Community sentiment remains fixated on the fund's strategic allocation to space infrastructure leaders, with many viewing the basket approach as a safer, long-term play compared to individual stock volatility.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are flocking to XOVR as a liquid and NAV-aligned vehicle to gain indirect exposure to SpaceX, with ongoing community debate comparing its structure to other SpaceX-exposed funds like DXYZ and ARKVX. The primary catalyst fueling discourse is the highly anticipated prospect of a SpaceX IPO, which traders believe could act as a significant price catalyst for the ETF.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is gaining momentum as investors pivot toward durable, cash-generative payment networks while monitoring potential regulatory shifts like credit card interest rate caps. The community remains focused on the company's resilience, its strategic push into AI and blockchain-based infrastructure, and its ability to maintain growth through global transaction volume.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is rallying as investors react to headlines regarding a potential diplomatic framework between the U.S. and Iran, with the community actively debating whether this is a legitimate breakthrough or another recurring market-pumping tactic. While some participants are leaning into bullish momentum driven by the prospect of reopened shipping routes and lower energy costs, many remain skeptical of the news and are closely monitoring technical resistance levels for signs of a potential reversal.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as investors aggressively position themselves ahead of the upcoming SpaceX IPO, viewing the company as a high-leverage "space-tug" infrastructure play with a low market cap. The community is heavily focused on the company's recent debt retirement, insider accumulation, and critical orbital successes, with active discussions centering on the potential for a short squeeze due to limited float.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is surging as investors react to a robust earnings report that highlighted strong revenue growth, rapid store expansion, and the debut of a significant share buyback program. The community is actively debating the implications of this buyback, with many seeing it as a long-awaited sign of management's confidence and a strategic precursor to a potential relisting on a major exchange.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors grapple with conflicting macroeconomic signals, including rising U.S. bond yields, shifting geopolitical risks in the Middle East, and persistent inflation concerns. The community is actively debating the ETF's role as a traditional safe-haven hedge versus its recent correlation with equity market volatility, while monitoring central bank accumulation and potential shifts in interest rate policies.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending as investors react to a significant earnings beat and news of a capitalization deal with Cerberus, while the community intensely debates the stock's massive short interest and potential for a squeeze. Traders are split between viewing the recent price volatility as a manipulative sell-off driven by trapped shorts and concerns over future dilution or execution risks.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending as futures rally on market optimism surrounding shifting negotiations with Iran, despite ongoing skepticism from traders regarding the durability of a potential deal. The community is sharply divided, with bulls pointing to historical market strength and AI-driven growth, while bears highlight the lack of a finalized agreement and caution against excessive FOMO-driven buying.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing extreme volatility driven by a major institutional stake disclosure from Leopold Aschenbrenner's fund, which triggered a massive rally and short-squeeze chatter. While the community is debating whether this is a legitimate long-term infrastructure play or a speculative momentum pump, bullish sentiment remains high as traders look for the next leg up toward double digits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It PR Newswire NEW YORK, May 22, 2026 Issued on behalf of Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ...

Mesoblast (NASDAQ:MESO) Shares Cross Above Fifty Day Moving Average   - Here's Why

Mesoblast (NASDAQ:MESO) Stock Price Crosses Above Fifty Day Moving Average - Here's Why...

Mesoblast (NASDAQ:MESO) Shares Gap Up   - Should You Buy?

Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next...

Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced the acquisition of an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform. This innovation is designed to enhance the precision and effectiveness of Mesoblast's mesenchymal lineage st...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Buys 1,586,890 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the company's stock in a transaction dated Thursday, April 9th. The stock was acquired at an...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 1,586,890 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the firm's stock in a transaction dated Thursday, April 9th. The shares were purchased at an...

Gregory George Acquires 2,324,072 Shares of Mesoblast (NASDAQ:MESO) Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George bought 2,324,072 shares of the business's stock in a transaction on Friday, April 10th. The stock was acquired at an average cost of $1.48 per share, for a total transaction of $3,439,626.56. Following the acquisition, the...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 4,000,000 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George purchased 4,000,000 shares of the business's stock in a transaction on Saturday, April 4th. The stock was purchased at an average cost of $1.42 per share, with a total value of $5,680,000.00. Following the completion of the...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Acquires 1,981,890 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George purchased 1,981,890 shares of the stock in a transaction dated Thursday, April 9th. The shares were purchased at an average price of $8.59 per share, for a total transaction of $17,024,435.10. Following the completion of the...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Acquires 2,324,072 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 2,324,072 shares of Mesoblast stock in a transaction that occurred on Friday, April 10th. The stock was acquired at an average cost of $1.48 per share, with a total value of $3,439,626.56. Following the completion of...

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

MESO
Mesoblast limited.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest MESO News

MESOMesoblast limited.